original ) (raw )Pharmacological Treatment of Child and Adolescent Disruptive Behaviour Disorders: Between the Scylla and Charybdis, What Do the Data Say?
Thomas Wilkes
Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2015
View PDFchevron_right
Unanswered Questions Regarding Atypical Antipsychotic Use in Aggressive Children and Adolescents
Kimberly Hoagwood
Journal of Child and Adolescent Psychopharmacology, 2005
View PDFchevron_right
Current pharmacotherapy options for conduct disorders in adolescents and children
sohil khan
Expert Opinion on Pharmacotherapy, 2019
View PDFchevron_right
Psychopharmacological treatment of disruptive behavior in youths: systematic review and network meta-analysis
Aatiya Ahmad
Scientific Reports
View PDFchevron_right
Expert Opinion on Pharmacotherapy Current pharmacotherapy options for conduct disorders in adolescents and children Current pharmacotherapy options for conduct disorders in adolescents and children
Brett McDermott
Expert Opinion on Pharmacotherapy, 2018
View PDFchevron_right
Treatment Recommendations for the Use of Antipsychotics for Aggressive Youth (TRAAY). Part II
Chip Felton
Journal of The American Academy of Child and Adolescent Psychiatry, 2003
View PDFchevron_right
Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). part I: A review
Kim Van Orden
Journal of the American …, 2003
View PDFchevron_right
Neuropsychological Characterization of Aggressive Behavior in Children and Adolescents with CD/ODD and Effects of Single Doses of Medications: The Protocol of the Matrics_WP6-1 Study
federica donno
Brain Sciences
View PDFchevron_right
Risperidone for the treatment of affective symptoms in children with disruptive behavior disorder: A post hoc analysis of data from a 6-week, multicenter, randomized, double-blind, parallel-arm study
Janet Wozniak
Clinical Therapeutics, 2006
View PDFchevron_right
Psychopharmacology of aggression in children and adolescents with primary neuropsychiatric disorders: A review of current and potentially promising treatment options
Alexander Kolevzon
2010
View PDFchevron_right
Efficacy of atypical antipsychotic medication in the management of behaviour problems in children with intellectual disabilities and borderline intelligence: A systematic review
Gemma Unwin
Research in Developmental Disabilities, 2011
View PDFchevron_right
A Naturalistic Comparison of Methylphenidate and Risperidone Monotherapy in Drug-Naive Youth With Attention-Deficit/Hyperactivity Disorder Comorbid With Oppositional Defiant Disorder and Aggression
Gabriele Masi
Journal of Clinical Psychopharmacology, 2017
View PDFchevron_right
Antipsychotics for aggressive adolescents: barriers tobest practice
Peter Jensen
Expert Review of Neurotherapeutics, 2003
View PDFchevron_right
Pharmacotherapy of conduct disorders
Brett McDermott
Journal of Psychopharmacology, 2016
View PDFchevron_right
Antipsychotics for aggression in adults: A meta-analysis
Michael Bloch
Progress in neuro-psychopharmacology & biological psychiatry, 2017
View PDFchevron_right
Psychopharmacology and Aggression: II. A Meta-Analysis of Nonstimulant Medication Effects on Overt Aggression-Related Behaviors in Youth with SED
Ronald Steingard
Journal of Emotional and Behavioral Disorders, 2003
View PDFchevron_right
Effects of Risperidone on Conduct and Disruptive Behavior Disorders in Children With Subaverage IQs
Michael Aman
Journal of the American Academy of Child & Adolescent Psychiatry, 2002
View PDFchevron_right
Pharmacotherapy of aggression in children and adolescents: efficacy and effect size
Peter Jensen
Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Académie canadienne de psychiatrie de l'enfant et de l'adolescent, 2006
View PDFchevron_right
Long-Term, Open-Label Study of Risperidone in Children With Severe Disruptive Behaviors and Below-Average IQ
Albert Derivan
American Journal of Psychiatry, 2004
View PDFchevron_right
Clozapine: Its Impact on Aggressive Behavior Among Children and Adolescents With Schizophrenia
Sanjiv Kumra , Anne Frederickson
Journal of the American Academy of Child & Adolescent Psychiatry, 2005
View PDFchevron_right
Implementation and evaluation of a curriculum on the assessment and treatment of disruptive behaviour disorders
Asif Doja
Paediatrics & Child Health, 2021
View PDFchevron_right
Management of psychiatric disorders in children and adolescents with atypical antipsychotics
Aman A'morning
European Child & Adolescent Psychiatry, 2007
View PDFchevron_right
An open-label trial of aripiprazole in the treatment of aggression in male adolescents diagnosed with conduct disorder
Samuel Kuperman
Annals of Clinical Psychiatry Official Journal of the American Academy of Clinical Psychiatrists, 2011
View PDFchevron_right
Long-Term Safety and Efficacy of Risperidone for the Treatment of Disruptive Behavior Disorders in Children With Subaverage IQs
Sandra Fisman
PEDIATRICS, 2002
View PDFchevron_right
Risperidone in the treatment of conduct disorder in preschool children without intellectual disability
Sibel Durak
Child and Adolescent Psychiatry and Mental Health, 2011
View PDFchevron_right
The effectiveness of antipsychotic medication in the management of behaviour problems in adults with intellectual disabilities
Gemma Unwin
Journal of Intellectual Disability Research, 2007
View PDFchevron_right
Pharmacologic Management of Aggression in Adults with Intellectual Disability
Lifescience Global Canada
Journal of Intellectual Disability - Diagnosis and Treatment, 2013
View PDFchevron_right